Title:
NOVEL ANTI-CTLA4 ANTIBODIES
Document Type and Number:
WIPO Patent Application WO/2018/068182
Kind Code:
A1
Abstract:
The present disclosure provides antibodies and antigen binding fragments against CTLA4, which can block the binding of CTLA4 to its ligand. The antibodies of disclosure provide agents for treating diseases, such as cancer.
Inventors:
SUN ZIYONG (CN)
ZHOU MAN (CN)
MA WENCUI (CN)
MA HONGLI (CN)
CHEN WEI (CN)
ZHOU MAN (CN)
MA WENCUI (CN)
MA HONGLI (CN)
CHEN WEI (CN)
Application Number:
PCT/CN2016/101681
Publication Date:
April 19, 2018
Filing Date:
October 10, 2016
Export Citation:
Assignee:
CROWN BIOSCIENCE TAICANG INC (CN)
International Classes:
A61K39/395; A61K45/00; A61P35/00; C07K16/28
Domestic Patent References:
| WO2013142796A2 | 2013-09-26 |
Foreign References:
| CN105296433A | 2016-02-03 |
Other References:
DATABASE GenBank [O] 10 March 2016 (2016-03-10), KURAOKA, M. ET AL., XP055476773, Database accession no. KU257259.1
DATABASE GenBank [O] 26 July 2016 (2016-07-26), MYLVAGANAM ET AL., XP055476781, Database accession no. X60684.1
See also references of EP 3522922A4
DATABASE GenBank [O] 26 July 2016 (2016-07-26), MYLVAGANAM ET AL., XP055476781, Database accession no. X60684.1
See also references of EP 3522922A4
Attorney, Agent or Firm:
JUN HE LAW OFFICES (CN)
Download PDF: